Factors associated with significant liver fibrosis assessed using transient elastography in general population

World Journal of Gastroenterology

Volumn 21, Issue 4, 2015, Pages 1158-1166

  You, Seng Chan ^a   Kim, Kwang Joon ^a   Kim, Seung Up ^a,b   Kim, Beom Kyung ^a,b   Park, Jun Yong ^a,b   Kim, Do Young ^a,b   Ahn, Sang Hoon ^a,b   Lee, Won Jae ^c   Han, Kwang Hyub ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Liver Cirrhosis Clinical Research Center   (South Korea)

^c Seoul Gookgwain School   (South Korea)

Author keywords

Alanine aminotransferase; Body mass index; Carotid artery plaque; Carotid intimal medial thickness; Fibroscan; Healthy subjects; Liver fibrosis; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Transient elastography

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CAROTID ATHEROSCLEROSIS; ECHOGRAPHY; ELASTOGRAPHY; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIVER FIBROSIS; MALE; MIDDLE AGED; NORMAL HUMAN; OBESITY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SIGNIFICANT LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASES; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMORBIDITY; LIVER; LIVER CIRRHOSIS; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; SEVERITY OF ILLNESS INDEX; SOUTH KOREA; STATISTICAL MODEL; VASCULAR CALCIFICATION;

AGED; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COMORBIDITY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULAR CALCIFICATION;

EID: 84921742080     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i4.1158     Document Type: Article

References (37)

1. Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, Sung IK, Sohn CI, Keum DK, Kim BI. Prevalence and risk factors of nonalcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006; 21: 138-143 [PMID: 16706825 doi: 10.1111/j.1440-1746.2005.04086.x]
2. Farrell GC, Wong VW, Chitturi S. NAFLD in Asia-as common and important as in the West. Nat Rev Gastroenterol Hepatol 2013; 10: 307-318 [PMID: 23458891 doi: 10.1038/nrgastro.2013.34]
3. Sorrentino P, Tarantino G, Conca P, Perrella A, Terracciano ML, Vecchione R, Gargiulo G, Gennarelli N, Lobello R. Silent non-alcoholic fatty liver disease-a clinical-histological study. J Hepatol 2004; 41: 751-757 [PMID: 15519647 doi: 10.1016/j.jhep.2004.07.010]
4. Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, Clark JM. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011; 343: d6891 [PMID: 22102439 doi: 10.1136/bmj.d6891]
5. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-1906 [PMID: 15940625 doi: 10.1053/j.gastro.2005.03.084]
6. Jung KS, Kim SU. Clinical applications of transient elastography. Clin Mol Hepatol 2012; 18: 163-173 [PMID: 22893866 doi: 10.3350/cmh.2012.18.2.163]
7. Abenavoli L, Beaugrand M. Transient elastography in nonalcoholic fatty liver disease. Ann Hepatol 2012; 11: 172-178 [PMID: 22345333]
8. Nahon P, Kettaneh A, Tengher-Barna I, Ziol M, de Lédinghen V, Douvin C, Marcellin P, Ganne-Carrié N, Trinchet JC, Beaugrand M. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol 2008; 49: 1062-1068 [PMID: 18930329 doi: 10.1016/j.jhep.2008.08.011]
9. Chon YE, Choi EH, Song KJ, Park JY, Kim do Y, Han KH, Chon CY, Ahn SH, Kim SU. Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis. PLoS One 2012; 7: e44930 [PMID: 23049764 doi: 10.1371/journal.pone.0044930]
10. Casey SP, Kemp WW, McLean CA, Topliss DJ, Adams LA, Roberts SK. A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease. Scand J Gastroenterol 2012; 47: 836-841 [PMID: 22519948 doi: 10.3109/00365521.2012.677955]
11. Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, Le Clesiau H, Beaugrand M. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a communitybased population aged over 45 years. Gut 2011; 60: 977-984 [PMID: 21068129 doi: 10.1136/gut.2010.221382]
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419 [PMID: 3899825 doi: 10.1007/BF00280883]
13. Hong JW, Kim JY, Kim YE, Lee EJ. Metabolic parameters and nonalcoholic fatty liver disease in hypopituitary men. Horm Metab Res 2011; 43: 48-54 [PMID: 20865648 doi: 10.1055/s-0030-1265217]
14. Kim SU, Ahn SH, Park JY, Kang W, Kim do Y, Park YN, Chon CY, Han KH. Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. J Clin Gastroenterol 2009; 43: 267-271 [PMID: 18987556 doi: 10.1097/MCG.0b013e31816f212e]
15. Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin Res Hepatol Gastroenterol 2012; 36: 13-20 [PMID: 21920839 doi: 10.1016/j.clinre.2011.08.001]
16. Kim BK, Kim SU, Choi GH, Han WK, Park MS, Kim EH, Park JY, Kim do Y, Choi JS, Yang SC, Choi EH, Song K, Ahn SH, Han KH, Chon CY. "Normal" liver stiffness values differ between men and women: a prospective study for healthy living liver and kidney donors in a native Korean population. J Gastroenterol Hepatol 2012; 27: 781-788 [PMID: 22098121 doi: 10.1111/j.1440-1746.2011.06962.x]
17. Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, Choi PC, Kowo M, Chan AW, Merrouche W, Sung JJ, de Lédinghen V. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51: 454-462 [PMID: 20101745 doi: 10.1002/hep.23312]
18. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419 [PMID: 10348825 doi: 10.1016/S0016-5085(99)70506-8]
19. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865-873 [PMID: 17006923 doi: 10.1002/hep.21327]
20. Lee S, Jin Kim Y, Yong Jeon T, Hoi Kim H, Woo Oh S, Park Y, Soo Kim S. Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a crosssectional case-control study. Scand J Gastroenterol 2006; 41: 566-572 [PMID: 16638699 doi: 10.1080/00365520500319591]
21. Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008; 49: 600-607 [PMID: 18672311 doi: 10.1016/j.jhep.2008.06.012]
22. Verma S, Jensen D, Hart J, Mohanty SR. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int 2013; 33: 1398-1405 [PMID: 23763360 doi: 10.1111/liv.12226]
23. Dam-Larsen S, Franzmann M, Andersen IB, Christoffersen P, Jensen LB, Sørensen TI, Becker U, Bendtsen F. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 2004; 53: 750-755 [PMID: 15082596 doi: 10.1136/gut.2003.019984]
24. Söderberg C, Stål P, Askling J, Glaumann H, Lindberg G, Marmur J, Hultcrantz R. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010; 51: 595-602 [PMID: 20014114 doi: 10.1002/hep.23314]
25. Lee SS, Byoun YS, Jeong SH, Kim YM, Gil H, Min BY, Seong MH, Jang ES, Kim JW. Type and cause of liver disease in Korea: single-center experience, 2005-2010. Clin Mol Hepatol 2012; 18: 309-315 [PMID: 23091812 doi: 10.3350/cmh.2012.18.3.309]
26. Wu WC, Wu CY, Wang YJ, Hung HH, Yang HI, Kao WY, Su CW, Wu JC, Chan WL, Lin HC, Lee FY, Lee SD. Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects. Aliment Pharmacol Ther 2012; 36: 560-568 [doi: 10.1111/j.1365-2036.2012.05224.x]
27. Park HN, Sinn DH, Gwak GY, Kim JE, Rhee SY, Eo SJ, Kim YJ, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease. Liver Int 2012; 32: 937-944 [PMID: 22260521 doi: 10.1111/j.1478-3231.2011.02749.x]
28. Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, Rafiq N, Goodman Z, Younossi Z. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009; 7: 1224-1229 [PMID: 19559819 doi: 10.1016/j.cgh.2009.06.007]
29. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004; 328: 983 [PMID: 15028636 doi: 10.1136/bmj.38050.593634.63]
30. Kim BK, Han KH, Ahn SH. "Normal" range of alanine aminotransferase levels for Asian population. J Gastroenterol Hepatol 2011; 26: 219-220 [PMID: 21261710 doi: 10.1111/j.1440-1746.2010.06603.x]
31. Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008; 48: 606-613 [PMID: 18222014 doi: 10.1016/j.jhep.2007.11.020]
32. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004; 114: 147-152 [PMID: 15254578 doi: 10.1172/JCI200422422]
33. Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, Cigolini M, Falezza G, Arcaro G. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006; 29: 1325-1330 [PMID: 16732016 doi: 10.2337/dc06-0135]
34. Chon YE, Jung KS, Kim SU, Park JY, Park YN, Kim do Y, Ahn SH, Chon CY, Lee HW, Park Y, Han KH. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. Liver Int 2014; 34: 102-109 [PMID: 24028214 doi: 10.1111/liv.12282]
35. Organization for Economic Co-operation and Development. Health at a Glance 2011 [Internet]. Paris: Organisation for Economic Cooperation and Development; 2011. Available from: URL: http://www.oecd-ilibrary:content/book/health-glance-2011-en
36. Korean national health and nutrition examination survey. Available from: URL: http://knhanes.cdc.go.kr/
37. Lee YH, Shin MH, Kweon SS, Rhee JA, Ryu SY, Ahn HR, Choi JS. Metabolic syndrome and carotid artery parameter in Koreans aged 50 years and older. Circ J 2010; 74: 560-566 [PMID: 20103972 doi: 10.1253/circj.CJ-09-0477]